, Jan. 30, 2014 /PRNewswire/ -- ARC Group Worldwide, Inc. (NASDAQ: ARCW; the "Company" or "ARC") announced today that the Company's Divisions, ARC MIM and 3DMT, will exhibit at the nation's largest medical device event, MedTech World MD&M West.
Given the Company's reputation as a leader in the medical device manufacturing market, ARC MIM and 3DMT are pleased to present their capabilities at the MedTech conference. This is the 29
year of the MedTech MD&M West conference, with attendees including top decision makers from all segments of the medical device industry.
ARC MIM will be showcasing its world class MIM operations with AFT Colorado, AFT Hungary, FloMet, and Injectamax, as well as its cutting edge metal and plastic 3D printing capabilities through 3DMT. ARC MIM and 3DMT provide a number of high quality manufacturing services for medical device customers to help them solve complex solutions and get to market quickly.
The exhibit hours for MedTech MD&M West 2014 in
, are as follows:
- Tuesday, February 11 th: 10am – 5pm
- Wednesday, February 12 th: 10am – 5pm
- Thursday, February 13 th: 10am – 4pm
The ARC MIM and 3DMT teams will be located at Booth #2943 for the duration of the conference.
About ARC Group Worldwide, Inc.
ARC Group Worldwide is a diversified, global advanced manufacturing company, as well as a world leader in MIM. ARC was founded in 1987 and has a long history as a technology innovator in manufacturing. ARC has significant expertise in lean manufacturing and utilizes cutting edge technology including robotics, automation, and 3D printing. ARC's mission is to bring innovation and technology to manufacturing. The Company provides a holistic manufacturing solution to help its customers get to market quickly. ARC's core manufacturing businesses are in precision components, 3D printing, flanges, fittings, and wireless technology, through its operating subsidiaries:
. For more information about ARC Group Worldwide, please visit
This press release may contain "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995, which are based on ARC's current expectations, estimates and projections about future events. These include, but are not limited to, statements, if any, regarding business plans, pro-forma statements and financial projections, ARC's ability to expand its services and realize growth. These statements are not historical facts or guarantees of future performance, events or results. Such statements involve potential risks and uncertainties, and the general effects of financial, economic, and regulatory conditions affecting our industries. Accordingly, actual results may differ materially. ARC does not have any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For additional factors that may affect future results, please see filings made by ARC with the Securities and Exchange Commission ("SEC"), including its Form 10-K for the fiscal year ended
June 30, 2013
and Form 10-Q for the period ended
September 30, 2013
, as well as current reports on Form 8-K filed from time-to-time with the SEC.
CONTACT: Drew Kelley
PHONE: (303) 467-5236
SOURCE ARC Group Worldwide, Inc.